arXiv · 2101.11723
Development of a PET/EPRI combined imaging system for assessing tumor hypoxia
Abstract
Precise quantitative delineation of tumor hypoxia is essential in radiation therapy treatment planning to improve the treatment efficacy by targeting hypoxic sub-volumes. We developed a combined imaging system of positron emission tomography (PET) and electron para-magnetic resonance imaging (EPRI) of molecular oxygen to investigate the accuracy of PET imaging in assessing tumor hypoxia. The PET/EPRI combined imaging system aims to use EPRI to precisely measure the oxygen partial pressure in tissues. This will evaluate the validity of PET hypoxic tumor imaging by (near) simultaneously acquired EPRI as ground truth. The combined imaging system was constructed by integrating a small animal PET scanner (inner ring diameter 62 mm and axial field of view 25.6 mm) and an EPRI subsystem (field strength 25 mT and resonant frequency 700 MHz). The compatibility between the PET and EPRI subsystems were tested with both phantom and animal imaging. Hypoxic imaging on a tumor mouse model using $^{18}$F-fluoromisonidazole radio-tracer was conducted with the developed PET/EPRI system. We report the development and initial imaging results obtained from the PET/EPRI combined imaging system.
Explore related subjects
Keep this discovery
Heejong Kim, Boris Epel, Subramanian Sundramoorthy, Hsiu-Ming Tsai, Eugene Barth, Inna Gertsenshteyn, Howard Halpern, Yuexuan Hua, Qingguo Xie, Chin-Tu Chen, Chien-Min Kao. 2021-01-27. Development of a PET/EPRI combined imaging system for assessing tumor hypoxia. https://doi.org/10.1088/1748-0221%2F16%2F03%2Fp03031
Cite the original work for its findings. Save a collection to share your selection of sources.